LONDON (Reuters) - People taking NeuroSearch A/S's obesity pill tesofensine lost twice as much weight as men and women using approved weight loss drugs, Danish researchers said on Thursday. The study ...
COPENHAGEN, Sept 17 (Reuters) - Danish biotech firm NeuroSearch said on Monday it had achieved very positive results in a Phase IIb study in obesity with its drug candidate tesofensine, boosting its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results